Silence Therapeutics plc
SLN
$13.55
-$0.14-1.02%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.27M | -14.96M | -11.77M | -20.96M | -27.35M |
| Total Depreciation and Amortization | 108.00K | 106.00K | 113.00K | 156.00K | 148.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 903.00K | 1.90M | -736.00K | 848.00K | 9.92M |
| Change in Net Operating Assets | 12.78M | -2.66M | -4.89M | 9.06M | -4.50M |
| Cash from Operations | 1.52M | -15.60M | -17.29M | -10.89M | -21.78M |
| Capital Expenditure | -- | -- | 0.00 | -3.00K | -48.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 64.94M | 10.00M | -53.34M | 51.29M | -1.51M |
| Cash from Investing | 64.94M | 10.00M | -53.34M | 51.29M | -1.56M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.00K | -- | 0.00 | 0.00 | 1.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.00K | -- | 0.00 | 0.00 | 1.00K |
| Foreign Exchange rate Adjustments | -63.00K | -17.00K | -129.00K | -106.00K | 198.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 66.40M | -5.62M | -70.75M | 40.29M | -23.15M |